Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Thermo Fisher Unit to Use xMAP Tech to Identify Dx Applications

NEW YORK (GenomeWeb News) — Fisher HealthCare, a division of Thermo Fisher Scientific, and Luminex will use Luminex’s xMAP instruments and assays to jointly identify molecular diagnostic applications, Luminex said today.  
Luminex, which develop and manufacture resulting products, said that by granting Fisher the US rights to its xMAP technology it gains a sales avenue through Fisher’s sales teams, its “access to key clinical accounts,” and its “extensive logistics network.”
Financial terms of the deal were not released.